Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
30 participants
INTERVENTIONAL
2008-08-31
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Assessing Safety and Efficacy of B-cure Laser Treating Diabetic Chronic Wounds
NCT01493895
Laser Therapy for At-Home Treatment of DIabetic Foot Ulcers
NCT03687320
Laser Therapy for At-Home Treatment of DIabetic Foot Ulcers (LLL&DIAB-03)
NCT04796649
Effects and Feasibility of Photobiomodulation at 830nm Nanometers in the Treatment of Diabetic Ulcers
NCT07043868
Effectiveness of Blue Light for Hard-to-heal Wounds
NCT07042659
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
The device is emitting a sham light
Qray light therapy device-Sham
non curative light- the device emits the same broad light, but with very low intensity
2
The device is emitting curative light
Qray light therapy device
The light is filtered from harmful UV and InfraRed light and only light at wavelight of 405nm until 1000nm is delivered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Qray light therapy device
The light is filtered from harmful UV and InfraRed light and only light at wavelight of 405nm until 1000nm is delivered.
Qray light therapy device-Sham
non curative light- the device emits the same broad light, but with very low intensity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The ulcer was not better on prior treatment of various medical clinics.
* The patient has diabetic ulcer grade 1 or 2
Exclusion Criteria
* Patient is taking antibiotic
* Patient has ankle brachial index less than 0.7
* Patient is schedule to undergone revascularization surgery 10 weeks before the study
* Patient has photosensitive disease
* Patient has cancer
* Creatinine level is more than 2 mg%
* Patient is taking immunosuppressive medication.
* Pregnant women
* Dialysis patient
* Anaemic patients(less than 9 gr)
* Patient has Albumin level less than 3 mg%
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
QRay Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Qray
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Soroka Medical Center
Beersheba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
or003121107
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.